High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study. 1986

H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein

Fifteen patients with myelodysplastic/myeloproliferative disorders were treated with high-dose cytosine arabinoside therapy. While severe toxicity was produced in every patient, only two of the 15 patients entered complete remission and two achieved partial remission status. The therapeutic responses were confined to patients who had severe myelofibrosis of apparently recent onset.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D009196 Myeloproliferative Disorders Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE. Disorder, Myeloproliferative,Disorders, Myeloproliferative,Myeloproliferative Disorder
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D011289 Preleukemia Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria. Preleukemias
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
February 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
January 1985, Neoplasma,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
June 1985, Seminars in oncology,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
June 1985, Seminars in oncology,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
August 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
June 1987, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
July 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
May 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
January 1984, American journal of hematology,
H D Preisler, and A Raza, and M Barcos, and N Azarnia, and R Larson, and G Browman, and I Walker, and H Grunwald, and P D'Arrigo, and A Stein
August 1983, Blood,
Copied contents to your clipboard!